SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-22-123849
Filing Date
2022-04-27
Accepted
2022-04-27 17:01:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d334237dsc13g.htm SC 13G 42278
  Complete submission text file 0001193125-22-123849.txt   43532
Mailing Address 1717 MAIN STREET SUITE 3388 DALLAS TX 75201
Business Address 1717 MAIN STREET SUITE 3388 DALLAS TX 75201 (254) 244-5739
Vaxxinity, Inc. (Subject) CIK: 0001851657 (see all company filings)

IRS No.: 862083865 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93369 | Film No.: 22860733
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VAXXINITY, INC. 1717 MAIN ST STE. 3388 DALLAS TX 75201
Business Address
Reese Lou (Filed by) CIK: 0001890674 (see all company filings)

Type: SC 13G